1.2 GeV electron radiation spectra in thick tungsten single crystals and total radiation losses in tungsten, germanium and silicon single crystals

The experimental investigation of radiation energy losses of ultra relativistic electrons in aligned crystals of various atomic number are of great interest for several reasonye

Experimental Determination of the Characteristics of a Positron Source Using Channeling

Numerical simulations and `proof of principle' experiments showed clearly the interest of using crystals as photon generators dedicated to intense positron sources for linear colliders. An experimental investigation, using a 10 GeV secondary electron beam, of the SPS-CERN, impinging on an axially oriented thick tungsten crystal, has been prepared and operated between May and August 2000. After a short recall on the main features of positron sources using channeling in oriented crystals, the experimental set-up is described. A particular emphasis is put on the positron detector made of a drift chamber, partially immersed in a magnetic field. The enhancement in photon and positron production in the aligned crystal have been observed in the energy range 5 to 40 GeV, for the incident electrons, in crystals of 4 and 8 mm as in an hybrid target. The first results concerning this experiment are presented hereafter.Comment: 3 pages, 6 figures, submitted to Linac200

Analytical review of technical and tactical training of highly qualified athletes (men) who specialize in Sambo wrestling based on the results of the "2021 World Cup"

Пришва, О. Б. Аналітичний огляд техніко-тактичної підготовленості самбістів високої кваліфікації за підсумками «ЧС-2021» / Пришва О. Б., Драгунов Д. М., Голубничий М. В. та ін. // Науковий часопис НПУ імені М. П. Драгоманова. Серія 15: Науково-педагогічні проблеми фізичної культури (фізична культура і спорт). - 2022. - Вип. 3(148). - С. 109-115. - DOI: 10.31392/NPU-nc.series15.2022.3(148).24.Наведено аналітико-статистичний аналіз техніко-тактичної підготовленості висококваліфікованих самбістів, чемпіонів та призерів «ЧС – 2021». Рекомендовано провідним тренерам збірних команд областей України з боротьби самбо зосередити увагу на підвищенні показників активності та ефективності змагальних дій самбістів, а саме : удосконаленні техніко-тактичної підготовленості самбістів, а також покращенні їхніх показників підсистеми біологічного контролю.Taking into account the results of the analysis of scientific-methodical, special and reference literature, the members of the research group established, that the issue of analytical and statistical review of technical and tactical training of highly qualified athletes (Top 3 world rankings), who specialize in the sports section of Sambo wrestling as a result of their participation in the "World Cup – 2021" – insufficient number of specialized scientific and methodical works is devoted, which requires further research and emphasizes the relevance and practical component of the chosen field of study. The main purpose of the study is analytical and statistical analysis of technical and tactical training of highly qualified Sambo wrestlers (Top 3 world rankings, men), champions and winners of the 2021 World Cup (Tashkent, Uzbekistan). In the process of analytical and statistical work, the members of the research group used the following methods: abstraction, measurement, expert evaluation, survey, comparison, observation, etc. Leading coaches of the national teams of the regions of Ukraine in wrestling Sambo are recommended to focus on improving the activity and efficiency of competitive actions of Sambo wrestlers. Achieving the above indicators is possible under the following conditions: improving the technical and tactical training of Sambo wrestlers, as well as improving their performance subsystem biological control.Приведен аналитико-статистический анализ технико-тактической подготовленности высококвалифицированных самбистов, чемпионов и призеров «ЧМ-2021». Рекомендовано ведущим тренерам сборных команд областей Украины по борьбе самбо сосредоточить внимание на повышении показателей активности и эффективности соревновательных действий самбистов, а именно: усовершенствовании технико-тактической подготовленности самбистов, а также улучшении их показателей подсистемы биологического контроля

Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice

Aim. To study the effectiveness of Fortelyzin® in subgroups with different body weights in patients with ST-segment elevation acute myocardial infarction (STEMI) in the FRIDOM1 study and real clinical practice.Material and methods. Fortelyzin® was administered in a single-bolus dose of 15 mg over 10 seconds, regardless of the body weight of patients. Metalyse® was administered in a single-bolus dose of 30-50 mg over 10 seconds, depending on body weight. The one-year results of the FRIDOM1 study were evaluated by the clinical centers using telephone contact. Monitoring of Fortelyzin® use was carried out by inpatient physicians, emergency doctors and paramedics by filling out a monitoring sheet in the period from June 2013 to December 2021 in 19243 patients with STEMI.Results. In the FRIDOM1 study, the distribution of patients depending on body weight in the Fortelyzin® (n=190) and Metalyse® (n=191) drug groups was as follows: up to 60 kg — 4 people each (p=1,00); from 60 to 70 kg — 21 and 23 (p=0,87); from 70 to 80 kg — 39 and 43 (p=0,71), from 80 to 90 kg — 63 and 47 (p=0,07); from 90 to 100 kg — 30 and 41 (p=0,19); over 100 kg — 33 people (p=1,00) in each group. The effectiveness of thrombolysis according to electrocardiographic (ECG) data in the Fortelyzin® and Metalyse® groups was as follows: up to 60 kg — 75% each (p=1,00); from 60 to 70 kg — 76% vs 83% (p=0,72); from 70 to 80 kg — 82% vs 86% (p=0,76); from 80 to 90 kg — 81% vs 77% (p=0,64); from 90 to 100 kg — 80% vs 81% (p=1,00); over 100 kg — 79% vs 76% (p=1,00); in total — 80% vs 80% (p=0,87). The effectiveness of thrombolysis according to coronary angiography (CAG) (TIMI 2-3) in the Fortelyzin® and Metalyse® groups was as follows: up to 60 kg — 100% vs 50% (p=0,43); from 60 to 70 kg — 81% vs 67% (p=0,48); from 70 to 80 kg — 74% vs 84% (p=0,41); from 80 to 90 kg — 70% vs 72% (p=1,00); from 90 to 100 kg — 67% vs 66% (p=1,00); over 100 kg — 58% vs 64% (p=0,80); in total — 70% vs 71% (p=0,76). The one-year survival rate in the FRIDOM1 study in the Fortelyzin® and Metalyse® groups was 94% (p=0,91). The administration of Fortelyzin® in patients with STEMI caused blood flow restoration according to ECG data in 14624 of 19243 patients (76%), while according to CAG (TIMI 2-3) — in 3422 of 4805 patients (71%). Inhospital mortality was 5% (n=962), while intracranial hemorrhage developed in 0,5% (n=92).Conclusion. The use of Fortelyzin® in the FRIDOM1 study and in real clinical practice in a single-bolus (10 sec) dose of 15 mg in patients with STEMI with any body weight showed its high efficacy and safety, including at the prehospital stage

Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications

Superparamagnetic iron oxide nanoparticles can providemultiple benefits for biomedical applications in aqueous environments such asmagnetic separation or magnetic resonance imaging. To increase the colloidal stability and allow subsequent reactions, the introduction of hydrophilic functional groups onto the particles’ surface is essential. During this process, the original coating is exchanged by preferably covalently bonded ligands such as trialkoxysilanes. The duration of the silane exchange reaction, which commonly takes more than 24 h, is an important drawback for this approach. In this paper, we present a novel method, which introduces ultrasonication as an energy source to dramatically accelerate this process, resulting in high-quality waterdispersible nanoparticles around 10 nmin size. To prove the generic character, different functional groups were introduced on the surface including polyethylene glycol chains, carboxylic acid, amine, and thiol groups. Their colloidal stability in various aqueous buffer solutions as well as human plasma and serum was investigated to allow implementation in biomedical and sensing applications.status: publishe

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

WWW environmental information resources "ecological bridges"

Mimeograp

Orientation effects in ultrarelativistic electron transmission through a single crystal

The results of experimental investigations of the 1.2 GeV electron transmission dynamics in a thin single crystal of Si are discussed. The interpretation of the electron scattering orientation dependencies measured under different scattering angles is carried outyesBelgorod State Universit